DOCSLIB.ORG

KLF2 Induced

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
KLF2 Induced UvA-DARE (Digital Academic Repository) The transcription factor KLF2 in vascular biology Boon, R.A. Publication date 2008 Link to publication Citation for published version (APA): Boon, R. A. (2008). The transcription factor KLF2 in vascular biology. General rights It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons). Disclaimer/Complaints regulations If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible. UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl) Download date:23 Sep 2021 Supplementary data: Genes induced by KLF2 Dekker et al. LocusLink Accession Gene Sequence Description Fold p-value ID number symbol change (FDR) 6654 AK022099 SOS1 cDNA FLJ12037 fis, clone HEMBB1001921. 100.00 5.9E-09 56999 AF086069 ADAMTS9 full length insert cDNA clone YZ35C05. 100.00 1.2E-09 6672 AF085934 SP100 full length insert cDNA clone YR57D07. 100.00 6.7E-13 9031 AF132602 BAZ1B Williams Syndrome critical region WS25 mRNA, partial sequence. 43.78 2.9E-05 64919 AJ404614 BCL11B mRNA for B-cell lymphoma/leukaemia 11B (BCL11B gene). 37.11 9.2E-04 AF095854 asthmatic clone 2 mRNA, 3' UTR. 24.88 1.9E-03 3489 M62402 IGFBP6 insulin-like growth factor binding protein 6 (IGFBP6) mRNA, complete cds. 15.06 2.1E-07 8692 NM_003773 HYAL2 hyaluronoglucosaminidase 2 (HYAL2), transcript variant 1 . 12.67 6.7E-42 2199 NM_001998 FBLN2 fibulin 2 (FBLN2) . 10.90 6.7E-42 492304 AK025719 LOC492304 cDNA: FLJ22066 fis, clone HEP10611. 9.60 2.5E-41 1382 NM_001878 CRABP2 cellular retinoic acid binding protein 2 (CRABP2) . 9.12 2.0E-06 10365 NM_016270 KLF2 Kruppel-like factor 2 (lung) (KLF2) . 8.73 6.7E-42 22808 NM_012219 MRAS muscle RAS oncogene homolog (MRAS) . 8.32 6.7E-42 90809 AL137727 C14orf9 mRNA; cDNA DKFZp434M0519 (from clone DKFZp434M0519); partial cds. 7.62 1.9E-28 1514 NM_001912 CTSL cathepsin L (CTSL), transcript variant 1 . 7.58 6.7E-42 3554 NM_000877 IL1R1 interleukin 1 receptor, type I (IL1R1) . 7.56 7.7E-15 55600 NM_017625 ITLN1 intelectin 1 (galactofuranose binding) (ITLN1) . 7.53 6.7E-42 5744 NM_002820 PTHLH parathyroid hormone-like hormone (PTHLH) . 7.48 6.7E-42 5239 AL137698 PGM5 mRNA; cDNA DKFZp434C1915 (from clone DKFZp434C1915); partial cds. 6.83 1.5E-37 7148 Y17867 TNXB mRNA for tenascin-X (partial), fibronectin type III repeats h13-h16 and h13a. 6.78 2.1E-17 10100 AK022144 TSPAN2 cDNA FLJ12082 fis, clone HEMBB1002492. 6.61 2.2E-26 6405 NM_004186 SEMA3F sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F (SEMA3F) . 6.56 6.7E-42 10716 NM_006593 TBR1 T-box, brain, 1 (TBR1) . 6.48 5.8E-32 3783 NM_002250 KCNN4 potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 (KCNN4) . 6.38 6.7E-42 2006 NM_000501 ELN elastin (supravalvular aortic stenosis, Williams-Beuren syndrome) (ELN) . 6.12 1.5E-07 7056 NM_000361 THBD thrombomodulin (THBD) . 6.06 6.7E-42 10397 NM_006096 NDRG1 N-myc downstream regulated gene 1 (NDRG1) . 5.89 2.4E-27 79148 AF315683 MMP28 matrix metalloproteinase 28 (MMP28) mRNA, complete cds. 5.82 6.7E-42 6441 NM_003019 SFTPD surfactant, pulmonary-associated protein D (SFTPD) . 5.74 8.9E-39 4207 NM_005919 MEF2B MADS box transcription enhancer factor 2, polypeptide B (myocyte enhancer factor 2B) (MEF2B) . 5.73 6.7E-42 54941 AK027134 RNF125 cDNA: FLJ23481 fis, clone KAIA03003. 5.65 6.3E-11 1240 NM_004072 CMKLR1 chemokine-like receptor 1 (CMKLR1) . 5.53 1.1E-19 AL133656 mRNA; cDNA DKFZp434O2017 (from clone DKFZp434O2017). 5.42 2.1E-06 51365 NM_015900 PLA1A phospholipase A1 member A (PLA1A) . 5.42 3.5E-24 5730 NM_000954 PTGDS prostaglandin D2 synthase 21kDa (brain) (PTGDS) . 5.32 2.9E-27 7078 NM_000362 TIMP3 tissue inhibitor of metalloproteinase 3 (Sorsby fundus dystrophy, pseudoinflammatory) (TIMP3) . 5.27 1.2E-12 4056 NM_000897 LTC4S leukotriene C4 synthase (LTC4S), transcript variant 2 . 5.22 8.0E-08 6578 NM_005630 SLCO2A1 solute carrier family 21 (prostaglandin transporter), member 2 (SLC21A2) . 5.21 5.3E-37 Page 1 / 15 Supplementary data: Genes induced by KLF2 Dekker et al. 22997 AB028953 KIAA1030 mRNA for KIAA1030 protein, partial cds. 5.19 8.0E-04 57669 AK023922 EPB41L5 cDNA FLJ13860 fis, clone THYRO1001062. 4.95 3.9E-09 58494 AF255910 JAM2 vascular endothelial junction-associated molecule mRNA, complete cds. 4.88 1.3E-03 2169 NM_000134 FABP2 fatty acid binding protein 2, intestinal (FABP2) . 4.74 4.9E-07 1363 NM_001873 CPE carboxypeptidase E (CPE) . 4.55 1.2E-15 7761 NM_013249 ZNF214 zinc finger protein 214 (ZNF214) . 4.37 2.0E-26 S51971 insulin-like growinsulin-like growth factor-II {5' region} [, placenta, mRNA Partial, 100 nt]. 4.37 7.6E-32 55251 NM_018257 C20orf36 chromosome 20 open reading frame 36 (C20orf36) . 4.34 1.1E-25 10628 NM_006472 TXNIP thioredoxin interacting protein (TXNIP) . 4.32 6.7E-42 283174 AL133591 LOC283174 mRNA; cDNA DKFZp434N079 (from clone DKFZp434N079). 4.26 1.0E-03 1512 NM_004390 CTSH cathepsin H (CTSH), transcript variant 1 . 4.25 1.0E-21 10138 NM_005748 YAF2 YY1 associated factor 2 (YAF2) . 4.24 8.9E-15 23545 NM_012463 ATP6V0A2 ATPase, H+ transporting, lysosomal V0 subunit a isoform 2 (ATP6V0A2) . 4.22 5.0E-23 3481 NM_000612 IGF2 insulin-like growth factor 2 (somatomedin A) (IGF2) . 4.15 8.2E-08 79733 AK026964 FLJ23311 cDNA: FLJ23311 fis, clone HEP11681. 4.14 8.3E-16 994 NM_004358 CDC25B cell division cycle 25B (CDC25B), transcript variant 1 . 4.14 3.0E-05 8751 NM_003815 ADAM15 a disintegrin and metalloproteinase domain 15 (metargidin) (ADAM15) . 4.12 2.4E-10 25890 AL117664 ABI3BP mRNA; cDNA DKFZp586L2024 (from clone DKFZp586L2024); partial cds. 4.12 1.2E-12 7576 X52355 ZNF28 Kox24 mRNA for zinc finger protein, partial. 4.10 2.0E-32 10268 NM_005856 RAMP3 receptor (calcitonin) activity modifying protein 3 (RAMP3) . 4.08 7.5E-11 4798 NM_006165 NFRKB nuclear factor related to kappa B binding protein (NFRKB) . 4.00 1.5E-37 57178 AK025812 RAI17 cDNA: FLJ22159 fis, clone HRC00251. 3.96 6.7E-42 4584 M55406 MUC3A intestinal mucin (MUC-3) mRNA, partial cds. 3.96 9.9E-17 3241 NM_002149 HPCAL1 hippocalcin-like 1 (HPCAL1), transcript variant 1 . 3.94 8.3E-20 7851 U17077 BENE BENE protein . 3.93 5.2E-17 26112 AK023767 DKFZP434C171cDNA FLJ13705 fis, clone PLACE2000302. 3.92 2.5E-35 54888 NM_017755 NSUN2 hypothetical protein FLJ20303 (FLJ20303) . 3.86 4.2E-11 4856 NM_002514 NOV nephroblastoma overexpressed gene (NOV) . 3.84 1.3E-31 23512 AK024514 SUZ12 cDNA: FLJ20861 fis, clone ADKA01761. 3.80 1.9E-16 79887 AK026315 FLJ22662 cDNA: FLJ22662 fis, clone HSI08080. 3.74 2.5E-21 U84516 velo-cardio-facial syndrome 22q11 region mRNA sequence. 3.73 1.6E-35 79939 AK024313 SLC35E1 cDNA FLJ14251 fis, clone OVARC1001329. 3.72 5.6E-04 51152 NM_016181 LOC51152 melanoma antigen (LOC51152) . 3.70 1.8E-07 3488 AF055033 IGFBP5 clone 24645 insulin-like growth factor binding protein 5 (IGFBP5) mRNA, complete cds. 3.68 3.1E-12 55705 AF070633 IPO9 clone 24672 mRNA sequence. 3.65 1.6E-18 57007 U67784 CMKOR1 orphan G protein-coupled receptor (RDC1) mRNA, partial cds. 3.62 5.4E-23 608 Z29572 TNFRSF17 H.sapiens antisense mRNA for BCMA peptide. 3.60 1.0E-05 7102 NM_004615 TM4SF2 transmembrane 4 superfamily member 2 (TM4SF2) . 3.59 1.4E-17 4254 NM_000899 KITLG KIT ligand (KITLG) . 3.54 5.9E-08 55001 NM_017904 FLJ20619 hypothetical protein FLJ20619 (FLJ20619) . 3.50 1.8E-16 10855 NM_006665 HPSE heparanase (HPSE) . 3.49 1.9E-27 Page 2 / 15 Supplementary data: Genes induced by KLF2 Dekker et al. 55679 NM_017980 LIMS2 LIM and senescent cell antigen-like domains 2 (LIMS2) . 3.49 4.5E-09 50937 AK022986 cDNA FLJ12924 fis, clone NT2RP2004709. 3.48 1.0E-03 25890 AK025204 ABI3BP cDNA: FLJ21551 fis, clone COL06266. 3.46 2.6E-06 358 NM_000385 AQP1 aquaporin 1 (channel-forming integral protein, 28kDa) (AQP1), transcript variant 2 . 3.44 1.1E-13 2078 AK026868 ERG cDNA: FLJ23215 fis, clone ADSU01729. 3.43 2.8E-13 968 NM_001251 CD68 CD68 antigen (CD68) . 3.42 7.4E-28 144438 AK002085 LOC144438 cDNA FLJ11223 fis, clone PLACE1008209. 3.40 3.7E-06 56479 NM_019842 KCNQ5 potassium voltage-gated channel, KQT-like subfamily, member 5 (KCNQ5) . 3.40 5.6E-14 187 NM_005161 AGTRL1 angiotensin II receptor-like 1 (AGTRL1) . 3.40 8.0E-21 84859 AL137527 LRCH3 mRNA; cDNA DKFZp434P1018 (from clone DKFZp434P1018); partial cds. 3.40 4.7E-20 AK026826 cDNA: FLJ23173 fis, clone LNG10019. 3.37 2.8E-05 24138 NM_012420 IFIT5 retinoic acid- and interferon-inducible protein (58kD) (RI58) . 3.36 2.3E-15 10111 NM_005732 RAD50 RAD50 homolog (S. cerevisiae) (RAD50), transcript variant 1 . 3.34 1.4E-07 Z25424 H.sapiens protein-serine/threonine kinase gene, complete CDS. 3.33 7.7E-15 NM_005179 . 3.32 2.1E-10 57592 AB037862 KIAA1441 mRNA for KIAA1441 protein, partial cds. 3.32 9.4E-28 64073 AB038318 C19orf33 imup-2 mRNA for immortalization-upregulated protein 2, complete cds.
Load more

Recommended publications
  • A Genome-Wide Association Study of a Coronary Artery Disease Risk Variant
    Journal of Human Genetics (2013) 58, 120–126 & 2013 The Japan Society of Human Genetics All rights reserved 1434-5161/13 www.nature.com/jhg ORIGINAL ARTICLE A genome-wide association study of a coronary artery diseaseriskvariant Ji-Young Lee1,16, Bok-Soo Lee2,16, Dong-Jik Shin3,16, Kyung Woo Park4,16, Young-Ah Shin1, Kwang Joong Kim1, Lyong Heo1, Ji Young Lee1, Yun Kyoung Kim1, Young Jin Kim1, Chang Bum Hong1, Sang-Hak Lee3, Dankyu Yoon5, Hyo Jung Ku2, Il-Young Oh4, Bong-Jo Kim1, Juyoung Lee1, Seon-Joo Park1, Jimin Kim1, Hye-kyung Kawk1, Jong-Eun Lee6, Hye-kyung Park1, Jae-Eun Lee1, Hye-young Nam1, Hyun-young Park7, Chol Shin8, Mitsuhiro Yokota9, Hiroyuki Asano10, Masahiro Nakatochi11, Tatsuaki Matsubara12, Hidetoshi Kitajima13, Ken Yamamoto13, Hyung-Lae Kim14, Bok-Ghee Han1, Myeong-Chan Cho15, Yangsoo Jang3,17, Hyo-Soo Kim4,17, Jeong Euy Park2,17 and Jong-Young Lee1,17 Although over 30 common genetic susceptibility loci have been identified to be independently associated with coronary artery disease (CAD) risk through genome-wide association studies (GWAS), genetic risk variants reported to date explain only a small fraction of heritability. To identify novel susceptibility variants for CAD and confirm those previously identified in European population, GWAS and a replication study were performed in the Koreans and Japanese. In the discovery stage, we genotyped 2123 cases and 3591 controls with 521 786 SNPs using the Affymetrix SNP Array 6.0 chips in Korean. In the replication, direct genotyping was performed using 3052 cases and 4976 controls from the KItaNagoya Genome study of Japan with 14 selected SNPs.
    [Show full text]
  • A Single-Cell Transcriptional Atlas Identifies Extensive Heterogeneity in the Cellular Composition of Tendons
    bioRxiv preprint doi: https://doi.org/10.1101/801266; this version posted October 10, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. A single-cell transcriptional atlas identifies extensive heterogeneity in the cellular composition of tendons Jacob B Swanson1, Andrea J De Micheli2, Nathaniel P Disser1, Leandro M Martinez1, Nicholas R Walker1,3, Benjamin D Cosgrove2, Christopher L Mendias1,3,* 1Hospital for Special Surgery, New York, NY, USA 2Meining School of Biomedical Engineering, Cornell University, Ithaca, NY, USA 3Department of Physiology and Biophysics, Weill Cornell Medical College, New York, NY, USA *Corresponding Author Christopher Mendias, PhD Hospital for Special Surgery 535 E 70th St New York, NY 10021 USA +1 212-606-1785 [email protected] Keywords: tenocyte; tendon fibroblast; pericyte; single-cell RNA sequencing bioRxiv preprint doi: https://doi.org/10.1101/801266; this version posted October 10, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Tendon is a dense, hypocellular connective tissue that transmits forces between muscles and bones. Cellular heterogeneity is increasingly recognized as an important factor in the biological basis of tissue homeostasis and disease, but little is known about the diversity of cells that populate tendon. Our objective was to explore the heterogeneity of cells in mouse Achilles tendons using single-cell RNA sequencing. We identified 13 unique cell types in tendons, including 4 previously undescribed populations of fibroblasts.
    [Show full text]
  • Gentaur Products List
    Chapter 2 : Gentaur Products List • Rabbit Anti LAMR1 Polyclonal Antibody Cy5 Conjugated Conjugated • Rabbit Anti Podoplanin gp36 Polyclonal Antibody Cy5 • Rabbit Anti LAMR1 CT Polyclonal Antibody Cy5 • Rabbit Anti phospho NFKB p65 Ser536 Polyclonal Conjugated Conjugated Antibody Cy5 Conjugated • Rabbit Anti CHRNA7 Polyclonal Antibody Cy5 Conjugated • Rat Anti IAA Monoclonal Antibody Cy5 Conjugated • Rabbit Anti EV71 VP1 CT Polyclonal Antibody Cy5 • Rabbit Anti Connexin 40 Polyclonal Antibody Cy5 • Rabbit Anti IAA Indole 3 Acetic Acid Polyclonal Antibody Conjugated Conjugated Cy5 Conjugated • Rabbit Anti LHR CGR Polyclonal Antibody Cy5 Conjugated • Rabbit Anti Integrin beta 7 Polyclonal Antibody Cy5 • Rabbit Anti Natrexone Polyclonal Antibody Cy5 Conjugated • Rabbit Anti MMP 20 Polyclonal Antibody Cy5 Conjugated Conjugated • Rabbit Anti Melamine Polyclonal Antibody Cy5 Conjugated • Rabbit Anti BCHE NT Polyclonal Antibody Cy5 Conjugated • Rabbit Anti NAP1 NAP1L1 Polyclonal Antibody Cy5 • Rabbit Anti Acetyl p53 K382 Polyclonal Antibody Cy5 • Rabbit Anti BCHE CT Polyclonal Antibody Cy5 Conjugated Conjugated Conjugated • Rabbit Anti HPV16 E6 Polyclonal Antibody Cy5 Conjugated • Rabbit Anti CCP Polyclonal Antibody Cy5 Conjugated • Rabbit Anti JAK2 Polyclonal Antibody Cy5 Conjugated • Rabbit Anti HPV18 E6 Polyclonal Antibody Cy5 Conjugated • Rabbit Anti HDC Polyclonal Antibody Cy5 Conjugated • Rabbit Anti Microsporidia protien Polyclonal Antibody Cy5 • Rabbit Anti HPV16 E7 Polyclonal Antibody Cy5 Conjugated • Rabbit Anti Neurocan Polyclonal
    [Show full text]
  • Homeobox Gene Expression Profile in Human Hematopoietic Multipotent
    Leukemia (2003) 17, 1157–1163 & 2003 Nature Publishing Group All rights reserved 0887-6924/03 $25.00 www.nature.com/leu Homeobox gene expression profile in human hematopoietic multipotent stem cells and T-cell progenitors: implications for human T-cell development T Taghon1, K Thys1, M De Smedt1, F Weerkamp2, FJT Staal2, J Plum1 and G Leclercq1 1Department of Clinical Chemistry, Microbiology and Immunology, Ghent University Hospital, Ghent, Belgium; and 2Department of Immunology, Erasmus Medical Center, Rotterdam, The Netherlands Class I homeobox (HOX) genes comprise a large family of implicated in this transformation proces.14 The HOX-C locus transcription factors that have been implicated in normal and has been primarily implicated in lymphomas.15 malignant hematopoiesis. However, data on their expression or function during T-cell development is limited. Using degener- Hematopoietic cells are derived from stem cells that reside in ated RT-PCR and Affymetrix microarray analysis, we analyzed fetal liver (FL) in the embryo and in the adult bone marrow the expression pattern of this gene family in human multipotent (ABM), which have the unique ability to self-renew and thereby stem cells from fetal liver (FL) and adult bone marrow (ABM), provide a life-long supply of blood cells. T lymphocytes are a and in T-cell progenitors from child thymus. We show that FL specific type of hematopoietic cells that play a major role in the and ABM stem cells are similar in terms of HOX gene immune system. They develop through a well-defined order of expression, but significant differences were observed between differentiation steps in the thymus.16 Several transcription these two cell types and child thymocytes.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Steroid-Dependent Regulation of the Oviduct: a Cross-Species Transcriptomal Analysis
    University of Kentucky UKnowledge Theses and Dissertations--Animal and Food Sciences Animal and Food Sciences 2015 Steroid-dependent regulation of the oviduct: A cross-species transcriptomal analysis Katheryn L. Cerny University of Kentucky, [email protected] Right click to open a feedback form in a new tab to let us know how this document benefits ou.y Recommended Citation Cerny, Katheryn L., "Steroid-dependent regulation of the oviduct: A cross-species transcriptomal analysis" (2015). Theses and Dissertations--Animal and Food Sciences. 49. https://uknowledge.uky.edu/animalsci_etds/49 This Doctoral Dissertation is brought to you for free and open access by the Animal and Food Sciences at UKnowledge. It has been accepted for inclusion in Theses and Dissertations--Animal and Food Sciences by an authorized administrator of UKnowledge. For more information, please contact [email protected]. STUDENT AGREEMENT: I represent that my thesis or dissertation and abstract are my original work. Proper attribution has been given to all outside sources. I understand that I am solely responsible for obtaining any needed copyright permissions. I have obtained needed written permission statement(s) from the owner(s) of each third-party copyrighted matter to be included in my work, allowing electronic distribution (if such use is not permitted by the fair use doctrine) which will be submitted to UKnowledge as Additional File. I hereby grant to The University of Kentucky and its agents the irrevocable, non-exclusive, and royalty-free license to archive and make accessible my work in whole or in part in all forms of media, now or hereafter known.
    [Show full text]
  • 1 Metabolic Dysfunction Is Restricted to the Sciatic Nerve in Experimental
    Page 1 of 255 Diabetes Metabolic dysfunction is restricted to the sciatic nerve in experimental diabetic neuropathy Oliver J. Freeman1,2, Richard D. Unwin2,3, Andrew W. Dowsey2,3, Paul Begley2,3, Sumia Ali1, Katherine A. Hollywood2,3, Nitin Rustogi2,3, Rasmus S. Petersen1, Warwick B. Dunn2,3†, Garth J.S. Cooper2,3,4,5* & Natalie J. Gardiner1* 1 Faculty of Life Sciences, University of Manchester, UK 2 Centre for Advanced Discovery and Experimental Therapeutics (CADET), Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, UK 3 Centre for Endocrinology and Diabetes, Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, UK 4 School of Biological Sciences, University of Auckland, New Zealand 5 Department of Pharmacology, Medical Sciences Division, University of Oxford, UK † Present address: School of Biosciences, University of Birmingham, UK *Joint corresponding authors: Natalie J. Gardiner and Garth J.S. Cooper Email: [email protected]; [email protected] Address: University of Manchester, AV Hill Building, Oxford Road, Manchester, M13 9PT, United Kingdom Telephone: +44 161 275 5768; +44 161 701 0240 Word count: 4,490 Number of tables: 1, Number of figures: 6 Running title: Metabolic dysfunction in diabetic neuropathy 1 Diabetes Publish Ahead of Print, published online October 15, 2015 Diabetes Page 2 of 255 Abstract High glucose levels in the peripheral nervous system (PNS) have been implicated in the pathogenesis of diabetic neuropathy (DN). However our understanding of the molecular mechanisms which cause the marked distal pathology is incomplete. Here we performed a comprehensive, system-wide analysis of the PNS of a rodent model of DN.
    [Show full text]
  • Supplemental Table 3 - Male Genes Differentially Expressed > 1.5-Fold Among Strains in E11.5 XY Gonads
    Supplemental Table 3 - Male genes differentially expressed > 1.5-fold among strains in E11.5 XY gonads. Male genes differentially expressed between C57BL/6J and 129S1/SvImJ. Note: Positive fold values reflect male genes that are up regulated in C57BL/6J relative to 129S1/SvImJ. Fold Diff Gene symbol Genbank acc Description 10.77 Gcnt1 NM_173442 Mus musculus glucosaminyl (N-acetyl) transferase 1, core 2 (Gcnt1), mRNA [NM_173442] 5.50 Afp NM_007423 Mus musculus alpha fetoprotein (Afp), mRNA [NM_007423] 4.95 Hnf4a NM_008261 Mus musculus hepatic nuclear factor 4, alpha (Hnf4a), mRNA [NM_008261] 4.71 Ppp1r14c AK082372 Mus musculus 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230042N14 product:hypothetical protein, full insert sequence. [AK082372] 4.41 Gorasp2 AK020521 Mus musculus 12 days embryo embryonic body between diaphragm region and neck cDNA, RIKEN full-length enriched library, clone:9430094F20 product:inferred: golgi reassembly stacking protein 2, full insert sequence. [AK020521] 3.69 Tmc7 NM_172476 Mus musculus transmembrane channel-like gene family 7 (Tmc7), mRNA [NM_172476] 2.97 Mt2 NM_008630 Mus musculus metallothionein 2 (Mt2), mRNA [NM_008630] 2.62 Gstm6 NM_008184 Mus musculus glutathione S-transferase, mu 6 (Gstm6), mRNA [NM_008184] 2.43 Adhfe1 NM_175236 Mus musculus alcohol dehydrogenase, iron containing, 1 (Adhfe1), mRNA [NM_175236] 2.38 Txndc2 NM_153519 Mus musculus thioredoxin domain containing 2 (spermatozoa) (Txndc2), mRNA [NM_153519] 2.30 C030038J10Rik AK173336 Mus musculus mRNA for mKIAA2027
    [Show full text]
  • Angiogenic Patterning by STEEL, an Endothelial-Enriched Long
    Angiogenic patterning by STEEL, an endothelial- enriched long noncoding RNA H. S. Jeffrey Mana,b, Aravin N. Sukumara,b, Gabrielle C. Lamc,d, Paul J. Turgeonb,e, Matthew S. Yanb,f, Kyung Ha Kub,e, Michelle K. Dubinskya,b, J. J. David Hob,f, Jenny Jing Wangb,e, Sunit Dasg,h, Nora Mitchelli, Peter Oettgeni, Michael V. Seftonc,d,j, and Philip A. Marsdena,b,e,f,1 aInstitute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada; bKeenan Research Centre for Biomedical Science in the Li Ka Shing Knowledge Institute, St. Michael’s Hospital, University of Toronto, Toronto, ON M5B 1T8, Canada; cDonnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, ON M5S 3E2, Canada; dInstitute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON M5S 3G9, Canada; eDepartment of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada; fDepartment of Medical Biophysics, University of Toronto, Toronto, ON M5G 1L7, Canada; gArthur and Sonia Labatt Brain Tumour Research Institute, Hospital for SickKids, University of Toronto, Toronto, ON M5G 1X8, Canada; hDivision of Neurosurgery and Keenan Research Centre for Biomedical Science, St. Michael’s Hospital, University of Toronto, Toronto, ON M5B 1W8, Canada; iDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115; and jDepartment of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, ON M5S 3E5, Canada Edited by Napoleone Ferrara, University of California, San Diego, La Jolla, CA, and approved January 24, 2018 (received for review August 28, 2017) Endothelial cell (EC)-enriched protein coding genes, such as endothelial formation in vitro and blood vessel formation in vivo.
    [Show full text]
  • ONLINE SUPPLEMENTARY TABLE Table 2. Differentially Expressed
    ONLINE SUPPLEMENTARY TABLE Table 2. Differentially Expressed Probe Sets in Livers of GK Rats. A. Immune/Inflammatory (67 probe sets, 63 genes) Age Strain Probe ID Gene Name Symbol Accession Gene Function 5 WKY 1398390_at small inducible cytokine B13 precursor Cxcl13 AA892854 chemokine activity; lymph node development 5 WKY 1389581_at interleukin 33 Il33 BF390510 cytokine activity 5 WKY *1373970_at interleukin 33 Il33 AI716248 cytokine activity 5 WKY 1369171_at macrophage stimulating 1 (hepatocyte growth factor-like) Mst1; E2F2 NM_024352 serine-throenine kinase; tumor suppression 5 WKY 1388071_x_at major histocompatability antigen Mhc M24024 antigen processing and presentation 5 WKY 1385465_at sialic acid binding Ig-like lectin 5 Siglec5 BG379188 sialic acid-recognizing receptor 5 WKY 1393108_at major histocompatability antigen Mhc BM387813 antigen processing and presentation 5 WKY 1388202_at major histocompatability antigen Mhc BI395698 antigen processing and presentation 5 WKY 1371171_at major histocompatability antigen Mhc M10094 antigen processing and presentation 5 WKY 1370382_at major histocompatability antigen Mhc BI279526 antigen processing and presentation 5 WKY 1371033_at major histocompatability antigen Mhc AI715202 antigen processing and presentation 5 WKY 1383991_at leucine rich repeat containing 8 family, member E Lrrc8e BE096426 proliferation and activation of lymphocytes and monocytes. 5 WKY 1383046_at complement component factor H Cfh; Fh AA957258 regulation of complement cascade 4 WKY 1369522_a_at CD244 natural killer
    [Show full text]
  • Anti-Inflammatory Role of Curcumin in LPS Treated A549 Cells at Global Proteome Level and on Mycobacterial Infection
    Anti-inflammatory Role of Curcumin in LPS Treated A549 cells at Global Proteome level and on Mycobacterial infection. Suchita Singh1,+, Rakesh Arya2,3,+, Rhishikesh R Bargaje1, Mrinal Kumar Das2,4, Subia Akram2, Hossain Md. Faruquee2,5, Rajendra Kumar Behera3, Ranjan Kumar Nanda2,*, Anurag Agrawal1 1Center of Excellence for Translational Research in Asthma and Lung Disease, CSIR- Institute of Genomics and Integrative Biology, New Delhi, 110025, India. 2Translational Health Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, 110067, India. 3School of Life Sciences, Sambalpur University, Jyoti Vihar, Sambalpur, Orissa, 768019, India. 4Department of Respiratory Sciences, #211, Maurice Shock Building, University of Leicester, LE1 9HN 5Department of Biotechnology and Genetic Engineering, Islamic University, Kushtia- 7003, Bangladesh. +Contributed equally for this work. S-1 70 G1 S 60 G2/M 50 40 30 % of cells 20 10 0 CURI LPSI LPSCUR Figure S1: Effect of curcumin and/or LPS treatment on A549 cell viability A549 cells were treated with curcumin (10 µM) and/or LPS or 1 µg/ml for the indicated times and after fixation were stained with propidium iodide and Annexin V-FITC. The DNA contents were determined by flow cytometry to calculate percentage of cells present in each phase of the cell cycle (G1, S and G2/M) using Flowing analysis software. S-2 Figure S2: Total proteins identified in all the three experiments and their distribution betwee curcumin and/or LPS treated conditions. The proteins showing differential expressions (log2 fold change≥2) in these experiments were presented in the venn diagram and certain number of proteins are common in all three experiments.
    [Show full text]
  • System, Method and Software for Calculation of a Cannabis Drug Efficiency Index for the Reduction of Inflammation
    International Journal of Molecular Sciences Article System, Method and Software for Calculation of a Cannabis Drug Efficiency Index for the Reduction of Inflammation Nicolas Borisov 1,† , Yaroslav Ilnytskyy 2,3,†, Boseon Byeon 2,3,4,†, Olga Kovalchuk 2,3 and Igor Kovalchuk 2,3,* 1 Moscow Institute of Physics and Technology, 9 Institutsky lane, Dolgoprudny, Moscow Region 141701, Russia; [email protected] 2 Department of Biological Sciences, University of Lethbridge, Lethbridge, AB T1K 3M4, Canada; [email protected] (Y.I.); [email protected] (B.B.); [email protected] (O.K.) 3 Pathway Rx., 16 Sandstone Rd. S., Lethbridge, AB T1K 7X8, Canada 4 Biomedical and Health Informatics, Computer Science Department, State University of New York, 2 S Clinton St, Syracuse, NY 13202, USA * Correspondence: [email protected] † First three authors contributed equally to this research. Abstract: There are many varieties of Cannabis sativa that differ from each other by composition of cannabinoids, terpenes and other molecules. The medicinal properties of these cultivars are often very different, with some being more efficient than others. This report describes the development of a method and software for the analysis of the efficiency of various cannabis extracts to detect the anti-inflammatory properties of the various cannabis extracts. The method uses high-throughput gene expression profiling data but can potentially use other omics data as well. According to the signaling pathway topology, the gene expression profiles are convoluted into the signaling pathway activities using a signaling pathway impact analysis (SPIA) method. The method was tested by inducing inflammation in human 3D epithelial tissues, including intestine, oral and skin, and then exposing these tissues to various extracts and then performing transcriptome analysis.
    [Show full text]